miR-342, a novel glucocorticoid-responsive miRNA necessary for Foxp3+ regulatory T cell function
miR-342,一种新的糖皮质激素反应性 miRNA,是 Foxp3 调节 T 细胞功能所必需的
基本信息
- 批准号:10671943
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-18 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAffectAnimal ModelAreaAutoimmunityBindingBiogenesisCell LineageCell physiologyChronicCytoplasmDefectDexamethasoneDiseaseEnsureExperimental Autoimmune EncephalomyelitisFOXP3 geneGene ExpressionGenerationsGenesGlucocorticoidsHomeostasisHumanHuman GenomeHypersensitivityImmuneImmunityImmunosuppressionInflammationInflammatoryInflammatory ResponseLeadMediatingMetabolicMicroRNAsModelingMolecularMusNucleotidesPatientsPlayPredispositionProteinsRefractoryRegulationRegulatory T-LymphocyteReportingResistanceRibonuclease IIIRoleSerumSteroid ResistanceSteroidsTestingTherapeutic EffectUntranslated RNAallergic airway inflammationattenuationautoimmune inflammationexosomeexperimental studyimmune activationmortalitymouse modelnovelnovel therapeutic interventionoverexpressionprogramsresponsetherapy development
项目摘要
Abstract
Foxp3+ regulatory T cells (Treg) are the central regulators of immunity and tolerance. Defects in Treg generation
and/or functions lead to lethal systemic autoimmune inflammation in both mice and human, demanding a tight
regulation of Treg homeostasis. Determining factors capable of modulating Treg function is thus a subject of
utmost importance. Among the factors is microRNA, a small non-coding RNA molecule known to regulate gene
expression. There is plethora of evidence that miRNAs play a critical role in Treg generation and functions.
However, our understanding the mechanisms by which Treg-derived miRNA modulates Treg functions is
relatively limited. Glucocorticoids are the frontline treatment option for many inflammatory diseases, including
autoimmunity and allergy. Despite the broad use, the precise immune suppressive mechanisms used by
glucocorticoids remain largely elusive. We recently reported that Tregs are indispensable during glucocorticoid-
induced treatment of chronic inflammation. Mechanistically, we uncovered that a novel miR-342 is induced by
glucocorticoid stimulation in Tregs and that miR-342 targets metabolic regulator, Rictor, to control Treg metabolic
programming. From the preliminary studies we also found that miR-342 is highly expressed in Tregs and that it
is further enhanced by dexamethasone (Dex) stimulation. Interestingly, miR-342 expression in Tregs appears to
be critical for Treg suppressive function. Moreover, miR-342 was also detected in the serum following Dex
treatment. To our surprise, Dex-induced serum miR-342 was detected in steroid-sensitive but not in steroid-
resistant inflammation. Based on the compelling evidence, we propose the hypothesis that miR-342 is a
glucocorticoid-induced miRNA in Tregs that plays a regulatory role in Tregs’ ability to control inflammation. Two
specific aims are proposed. First, we will determine the role of miR-342 in Treg functions. Two newly generated
animal models in which Tregs lack or overexpress miR-342 will be used. Second, we will examine the role of
Treg-derived miR-342 in steroid resistance. Identification of the mechanisms by which glucocorticoid-induced
miR-342 regulates Treg functions will open novel opportunities to develop therapies applicable to manage severe
inflammatory conditions including steroid resistance.
摘要
Foxp 3+调节性T细胞(Treg)是免疫和耐受的中心调节因子。Treg生成缺陷
和/或功能导致小鼠和人类的致命性全身性自身免疫炎症,需要严格的
调节Treg稳态。因此,能够调节Treg功能的决定因子是免疫调节的主题。
至关重要。其中一个因素是微小RNA,一种已知调节基因表达的小的非编码RNA分子。
表情有大量证据表明,miRNA在Treg的生成和功能中发挥关键作用。
然而,我们对Treg衍生的miRNA调节Treg功能的机制的理解,
相对有限。糖皮质激素是许多炎症性疾病的一线治疗选择,包括
自身免疫和过敏。尽管用途广泛,但免疫抑制剂使用的精确免疫抑制机制
糖皮质激素在很大程度上仍然是难以捉摸的。我们最近报道,TdR在糖皮质激素治疗中是不可或缺的-
诱导治疗慢性炎症。从机制上讲,我们发现一种新型的miR-342是由
TcG中的糖皮质激素刺激以及miR-342靶向代谢调节因子Rictor以控制Treg代谢
编程.从初步研究中我们还发现,miR-342在膀胱癌中高表达,
通过地塞米松(Dex)刺激进一步增强。有趣的是,miR-342在Tumor中的表达似乎
对Treg抑制功能至关重要。此外,在Dex后的血清中也检测到miR-342
治疗令我们惊讶的是,在类固醇敏感的人中检测到了右旋糖酐诱导的血清miR-342,而在类固醇敏感的人中没有检测到。
抵抗性炎症基于这些令人信服的证据,我们提出了一个假设,即miR-342是一种
糖皮质激素诱导的miRNA在TCRs中起调节作用,TCRs控制炎症的能力。两
提出了具体目标。首先,我们将确定miR-342在Treg功能中的作用。两个新生成的
将使用其中Tclase缺乏或过表达miR-342的动物模型。第二,我们将研究
Treg衍生的miR-342在类固醇抵抗中的作用确定糖皮质激素诱导的
miR-342调节Treg功能将为开发适用于管理严重
炎症性疾病,包括类固醇抵抗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Booki Min其他文献
Booki Min的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Booki Min', 18)}}的其他基金
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3 调节性 T 细胞依赖性糖皮质激素治疗过敏性炎症
- 批准号:
10447598 - 财政年份:2020
- 资助金额:
$ 20万 - 项目类别:
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3 调节性 T 细胞依赖性糖皮质激素治疗过敏性炎症
- 批准号:
10218031 - 财政年份:2020
- 资助金额:
$ 20万 - 项目类别:
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3 调节性 T 细胞依赖性糖皮质激素治疗过敏性炎症
- 批准号:
9982786 - 财政年份:2019
- 资助金额:
$ 20万 - 项目类别:
The role of IL-27/Lag3 axis in regulating Foxp3+ regulatory T cell function
IL-27/Lag3轴在调节Foxp3调节性T细胞功能中的作用
- 批准号:
10264303 - 财政年份:2017
- 资助金额:
$ 20万 - 项目类别:
Mechanism of basophil mediated immune modulation
嗜碱性粒细胞介导的免疫调节机制
- 批准号:
7897737 - 财政年份:2009
- 资助金额:
$ 20万 - 项目类别:
Mechanism of basophil mediated immune modulation
嗜碱性粒细胞介导的免疫调节机制
- 批准号:
7737907 - 财政年份:2009
- 资助金额:
$ 20万 - 项目类别:
相似海外基金
Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
- 批准号:
573541-2022 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
- 批准号:
2744317 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
- 批准号:
MR/V010948/1 - 财政年份:2021
- 资助金额:
$ 20万 - 项目类别:
Research Grant
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
- 批准号:
255762 - 财政年份:2012
- 资助金额:
$ 20万 - 项目类别:
Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
- 批准号:
20790351 - 财政年份:2008
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
- 批准号:
19370021 - 财政年份:2007
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
- 批准号:
7131841 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:














{{item.name}}会员




